The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor

This publication has 25 references indexed in Scilit:

• Cellular Stress Regulates the Nucleocytoplasmic Distribution of the Protein-tyrosine Phosphatase TCPTP
  Published by Elsevier ,2001
• Malignant glioma: genetics and biology of a grave matter
  Genes & Development, 2001
• Gliomagenesis: genetic alterations and mouse models
  Nature Reviews Genetics, 2001
• The T-cell protein tyrosine phosphatase
  Seminars in Immunology, 2000
• Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer
  British Journal of Cancer, 2000
• Development of “substrate-trapping” mutants to identify physiological substrates of protein tyrosine phosphatases
  Proceedings of the National Academy of Sciences, 1997
• The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
  Journal of Biological Chemistry, 1997
• Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway
  Journal of Biological Chemistry, 1996
• A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
  Proceedings of the National Academy of Sciences, 1994
• Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation
  Cell, 1990